Combined biological tests for suicide prediction

Psychiatry Research

Volumn 150, Issue 2, 2007, Pages 187-191

  Coryell, William ^a   Schlesser, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cholesterol; Cortisol; Depressive disorder; Dexamethasone suppression test

Indexed keywords

CHOLESTEROL; DEXAMETHASONE; HYDROCORTISONE; SEROTONIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DEPRESSIVE PSYCHOSIS; DEXAMETHASONE SUPPRESSION TEST; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NEUROTRANSMISSION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL BEHAVIOR; SUICIDE;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CHOLESTEROL; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SUICIDE; SURVIVAL ANALYSIS;

EID: 33847719472     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.01.021     Document Type: Article

References (44)

1. Alvarez J.C., Cremniter D., Lesieur P., Gregoire A., Gilton A., Macquin-Mavier I., Jarreau C., and Spreux-Varoquaux O. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biological Psychiatry 45 (1999) 1066-1069
2. Alvarez J.C., Cremniter D., Gluck N., Quintin P., Leboyer M., Berlin I., Therond P., and Spreux-Varoquaux O. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Research 95 (2000) 103-108
3. Atmaca M., Kuloglu M., Tezcan E., and Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatrica Scandinavica 108 (2003) 208-214
4. Barraclough B., Bunch J., Nelson B., and Sainsbury P. A hundred cases of suicide: clinical aspects. British Journal of Psychiatry 125 (1974) 355-373
5. Bocchetta A., Chillotti C., Carboni G., Oi A., Ponti M., and Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatrica Scandinavica 104 (2001) 37-41
6. Coryell W., and Schlesser M. The dexamethasone suppression test and suicide prediction. American Journal of Psychiatry 158 (2001) 748-753
7. Coryell W., and Young E. Suicide in primary MDD: a twenty-one year follow-up. Journal of Clinical Psychiatry 66 (2006) 283-290
8. Delva N.J., Matthews D.R., and Cowen P.J. Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs. Biological Psychiatry 39 (1996) 100-106
9. Dorovini-Zis K., and Zis A.P. Increased adrenal weight in victims of violent suicide. American Journal of Psychiatry 144 (1987) 1214-1215
10. Ellison L.F., and Morrison H.I. Low serum cholesterol concentration and risk of suicide. Epidemiology 12 (2001) 168-172
11. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35 (1978) 837-844
12. Favaro A., Caregaro L., Di Pascoli L., Brambilla F., and Santonastaso P. Total serum cholesterol and suicidality in anorexia nervosa. Psychosomatic Medicine 66 (2004) 548-552
13. Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., and Fogg L. Suicide: a four-pathway clinical-biochemical model. Annals of the New York Academy of Sciences 836 (1997) 288-301
14. Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., and Fersini C. Serum cholesterol concentrations in parasuicide. British Medical Journal 310 (1995) 1632-1636
15. Garland M., Hickey D., Corvin A., Golden J., Fitzpatrick P., Cunningham S., and Walsh N. Total serum cholesterol in relation to psychological correlates in parasuicide. British Journal of Psychiatry 177 (2000) 77-83
16. Goldstein R.B., Black D.W., Nasrallah A., and Winokur G. The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Archives of General Psychiatry 48 (1991) 418-422
17. Golomb B.A. Cholesterol and violence: is there a connection?. Annals of Internal Medicine 128 (1998) 478-487
18. Golomb B.A., Criqui M.H., White H., and Dimsdale J.E. Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry. Archives of Internal Medicine 164 (2004) 153-162
19. Guillem E., Pelissolo A., Notides C., and Lepine J.P. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Research 112 (2002) 83-88
20. Kim Y.K., and Myint A.M. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. Journal of Affective Disorders 81 (2004) 161-166
21. Kunugi H., Takei N., Aoki H., and Nanko S. Low serum cholesterol in suicide attempters. Biological Psychiatry 41 (1997) 196-200
22. Lindberg G., Rastam L., Gullberg B., and Eklund G.A. Low serum cholesterol concentration and short term mortality from injuries in men and women. British Medical Journal 305 (1992) 277-279
23. Mann J.J., Waternaux C., Haas G.L., and Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. American Journal of Psychiatry 156 (1999) 181-189
24. Mann J.J., Brent D.A., and Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24 (2001) 467-477
25. Modai I., Valevski A., Dror S., and Weizman A. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. Journal of Clinical Psychiatry 55 (1994) 252-254
26. Muldoon M.F., Kaplan J.R., Manuck S.B., and Mann J.J. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biological Psychiatry 31 (1992) 739-742
27. Neaton J.D., Blackburn H., Jacobs D., Kuller L., Lee D.J., Sherwin R., Shih J., Stamler J., and Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Archives of Internal Medicine 152 (1992) 1490-1500
28. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., and Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry 45 (1988) 577-579
29. Obrocea G.V., Dunn R.M., Frye M.A., Ketter T.A., Luckenbaugh D.A., Leverich G.S., Speer A.M., Osuch E.A., Jajodia K., and Post R.M. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biological Psychiatry 51 (2002) 253-260
30. Oquendo M.A., Russo S.A., Underwood M.D., Kassir S.A., Ellis S.P., Mann J.J., and Arango V. Higher Postmortem Prefrontal 5-HT(2A) Receptor Binding Correlates with Lifetime Aggression in Suicide. Biological Psychiatry 59 (2006) 235-243
31. Ozer O.A., Kutanis R., Agargun M.Y., Besiroglu L., Bal A.C., Selvi Y., and Kara H. Serum lipid levels, suicidality, and panic disorder. Comprehensive Psychiatry 45 (2004) 95-98
32. Papassotiropoulos A., Hawellek B., Frahnert C., Rao G.S., and Rao M.L. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 32 (1999) 1-4
33. Partonen T., Haukka J., Virtamo J., Taylor P.R., and Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. British Journal of Psychiatry 175 (1999) 259-262
34. Rao V.P., Krishnan K.R., Goli V., Saunders W.B., Ellinwood Jr. E.H., Blazer D.G., and Nemeroff C.B. Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. Biological Psychiatry 26 (1989) 729-732
35. Sarchiapone M., Roy A., Camardese G., and De Risio S. Further evidence for low serum cholesterol and suicidal behaviour. Journal of Affective Disorders 61 (2000) 69-71
36. Schatzberg A.F., Orsulak P.J., Rothschild A.J., Salomon M.S., Lerbinger J., Kizuka P.P., Cole J.O., and Schildkraut J.J. Platelet MAO activity and the dexamethasone suppression test in depressed patients. American Journal of Psychiatry 140 (1983) 1231-1233
37. Schlesser M.A., Winokur G., and Sherman B.M. Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. Archives of General Psychiatry 37 (1980) 737-743
38. Spitzer R.L., Endicott J., and Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 35 (1978) 773-782
39. Steegmans P.H., Fekkes D., Hoes A.W., Bak A.A., van der Does E., and Grobbee D.E. Low serum cholesterol concentration and serotonin metabolism in men. British Medical Journal 312 (1996) 221
40. Szigethy E., Conwell Y., Forbes N.T., Cox C., and Caine E.D. Adrenal weight and morphology in victims of completed suicide. Biological Psychiatry 36 (1994) 374-380
41. Tanskanen A., Vartiainen E., Tuomilehto J., Viinamaki H., Lehtonen J., and Puska P. High serum cholesterol and risk of suicide. American Journal of Psychiatry 157 (2000) 648-650
42. Terao T., Yoshimura R., Ohmori O., Takano T., Takahashi N., Iwata N., Suzuki T., and Abe K. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biological Psychiatry 41 (1997) 974-978
43. Tripodianakis J., Markianos M., Sarantidis D., and Agouridaki M. Biogenic amine turnover and serum cholesterol in suicide attempt. European Archives of Psychiatry and Clinical Neuroscience 252 (2002) 38-43
44. Zureik M., Courbon D., and Ducimetiere P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. British Medical Journal 313 (1996) 649-651